AIGAmerican International Group, Inc. — stock analysis & sentiment

At $75.68, AIG sits in the lower half of a 52-week range that runs from $71.25 to $87.29 — roughly 6% above the low and about 13% below the high. That whole band is only about 22% wide from bottom to top, a fairly contained year of trading for a company with a market capitalization near $39 billion, and the current price places the stock closer to where it has bottomed than to where it has peaked.

The market is pricing those earnings at about 13.7 times trailing profit and 8.6 times forward estimates; the gap between the two reflects expectations of higher earnings ahead rather than any change in the current price. Price-to-book of 0.97 puts the shares just under stated book value, which is a common reference point for insurers. Underneath, the business converts about 11% of revenue into profit, while revenue itself is essentially flat year over year at 0.5% growth — so the profitability is steady rather than expanding. A beta of 0.51 means the stock has historically moved about half as much as the broad market in either direction, and the 2.64% dividend yield accounts for a meaningful share of what holders receive.

Recent coverage splits between the company and its surroundings. The AIG-specific items are about capital returned to shareholders — a piece framing it as a dividend name, another on buybacks — plus the completion of Onex's Convex acquisition alongside a strategic investment by AIG. The rest is sector and market context rather than company news: a forecast for the critical illness insurance market, commentary on what higher-for-longer interest rates mean for insurers, and broad daily market roundups in which AIG appears only as part of the wider tape. There is little in the flow tied to operating results specifically.